TPST logo

TPST
Tempest Therapeutics Inc

12,993
Mkt Cap
$12.71M
Volume
255,010.00
52W High
$13.13
52W Low
$2.40
PE Ratio
-0.26
TPST Fundamentals
Price
$3.12
Prev Close
$2.61
Open
$2.76
50D MA
$4.06
Beta
2.07
Avg. Volume
103,758.05
EPS (Annual)
-$19.50
P/B
1.83
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
News Placeholder
TPST Stock Plummets After Inking Deal To Acquire CAR-T Programs From Privately-Held Firm In All-Stock Transaction
The transaction is expected to close in early 2026, provided it receives all required approvals.
Stocktwits·2mo ago
News Placeholder
Why Tempest Therapeutics (TPST) Stock Is Down 45% Today
Tempest Therapeutics shares fell Wednesday after the announcement of an all-stock acquisition of dual-CAR T programs from Factor Bioscience.read more...
Benzinga·2mo ago
News Placeholder
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
Zacks·8mo ago
News Placeholder
Tempest Therapeutics Retail Chatter Explodes As Cancer Drug Developer Mulls Possible Merger
CEO Stephen Brady emphasized the company's strong data and regulatory momentum, pointing to Phase 2 results for amezalpat in advanced liver cancer and FDA clearance for a pivotal Phase 3 study.
Stocktwits·10mo ago
<
...
1
>

Latest TPST News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.